Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 February 2004 : Letter/Correspondence  

Treatment of huge uterine tumors thought to be benign in post-menopausal women

Takako Okamoto, Masafumi Koshiyama, Keiko Yamamoto

Med Sci Monit 2004; 10(2): CR43-45 :: ID: 11589

Abstract

Background:When we find a huge uterine myoma-like tumor after menopause, we are hesitant whether to recommend surgery or not.Material/Methods: In order to treat huge uterine tumors after menopause, we surgically removed a total of 25 uterine tumors over 10 cm in diameter from 25 post-menopausal women, and examined these tumors microscopically.Results: Clinical assesments of the 25 tumors before surgery indicated that 24 were myomas and one was a sarcoma, based on cytology-, sonography- and MR imaging-examinations. However, the postoperative histological results revealed 22 leiomyomas, one leiomyosarcoma, one endometrial stromal sarcoma and one endometrial carcinoma at Ic stage complicated by multiple leiomyomas. Overall, 12% of the tumors were malignant (3/25 cases) and 8.3% were false negative cases (2/24 cases; diagnosed as myoma uteri) among the cases of huge uterine tumors after menopause.Conclusions: When a huge uterine tumor after menopause is diagnosed clinically as myoma uteri, surgery should be recommended since there ia a significant chance of malignancy.

Keywords: Cytodiagnosis, Diagnosis, Differential, Endometrial Neoplasms - diagnosis, Endometrial Neoplasms - surgery, Leiomyoma - pathology, Leiomyoma - surgery, Leiomyosarcoma - pathology, Leiomyosarcoma - surgery, Postmenopause, Uterine Neoplasms - diagnosis, Uterine Neoplasms - pathology, Uterine Neoplasms - surgery, Cytodiagnosis, Diagnosis, Differential, Endometrial Neoplasms - surgery, Leiomyoma - surgery, Leiomyosarcoma - surgery, Postmenopause, Uterine Neoplasms - surgery

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750